Loading news...
Loading news...
Mercy BioAnalytics raised $59M Series B venture round, led by Paul Meister.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
Novalis BiotechLEAD | Venture Capital | — |
Sozo VenturesLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Corporate Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$100M
Top Valuation
-
Mercy BioAnalytics raised $59M in a Series B round.
The round was announced on 09/03/25.
The round was led by Paul Meister, Paul Meister, Rob Freelen.